China NT Pharma Group Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-69.00
-77.00
-68.00
-197.00
-225.00
-402.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
3.00
90.00
-15.00
-111.00
152.00
3.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-20.00
35.00
20.00
-213.00
-40.00
-50.00
Cash Flow from Investing Activities
0.00
-24.00
5.00
279.00
649.00
-234.00
Cash Flow from Financing Activities
24.00
-11.00
-34.00
-98.00
-627.00
221.00
Net Cash Inflow / Outflow
8.00
0.00
-4.00
-28.00
-39.00
-65.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
5.00
0.00
4.00
4.00
-20.00
-2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of China NT Pharma Group Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-69.0910801400296
103.943246104054
-172.00
-166.47%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
3.41205243237513
-47.3717774264479
50.00
107.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-20.6002530076669
112.471882692278
-132.00
-118.32%
Cash Flow from Investing Activities
-0.216844768501756
-96.748915880502
96.00
99.78%
Cash Flow from Financing Activities
24.5012903930134
-55.1903445457529
79.00
144.39%
Net Cash Inflow / Outflow
8.78546579584865
-40.770472253861
48.00
121.55%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
5.10127317900381
-1.30309451988417
6.00
491.47%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -158.51% vs 70.32% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-20.60
35.21
-158.51%






